Magenta Therapeutics, Inc. (MGTA): Price and Financial Metrics

Magenta Therapeutics, Inc. (MGTA): $11.19

0.94 (-7.74%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add MGTA to Watchlist
Sign Up

MGTA Price/Volume Stats

Current price $11.19 52-week high $12.14
Prev. close $0.76 52-week low $0.32
Day low $10.90 Volume 23,500
Day high $12.14 Avg. volume 848,835
50-day MA $0.78 Dividend yield N/A
200-day MA $0.75 Market Cap 679.06M

MGTA Stock Price Chart Interactive Chart >


Magenta Therapeutics, Inc. (MGTA) Company Bio


Magenta Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing medicines to bring the curative power of bone marrow transplant to patients. It is developing C100, C200, and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an ADC program to prevent acute graft and host diseases. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. The company was founded in 2015 and is based in Cambridge, Massachusetts.


MGTA Latest News Stream


Event/Time News Detail
Loading, please wait...

MGTA Latest Social Stream


Loading social stream, please wait...

View Full MGTA Social Stream

MGTA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -85.93%
5-year -94.49%
YTD N/A
2023 0.00%
2022 -91.08%
2021 -43.49%
2020 -48.28%
2019 165.96%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!